2-heteroarylamino-pyrimidine derivatives as kinase inhibitors

Details for Australian Patent Application No. 2008289135 (hide)

Owner IRM LLC

Inventors Li, Xiaolin; Loren, Jon; Molteni, Valentina; Nabakka, Juliet; Chianelli, Donatella; Liu, Xiaodong

Agent Davies Collison Cave

Pub. Number AU-B-2008289135

PCT Pub. Number WO2009/026204

Priority 60/957,240 22.08.07 US

Filing date 18 August 2008

Wipo publication date 26 February 2009

Acceptance publication date 23 February 2012

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/026204 Priority application(s): WO2009/026204

23 February 2012 Application Accepted

  Published as AU-B-2008289135

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008289148-Gene expression markers of recurrence risk in cancer patients after chemotherapy

2008289133-Multi-lumen catheter assembly